America’s Car-Mart, Inc. Announces Appointment of Chief Operating Officer ROGERS, Ark., Sept. 24, 2024 (GLOBE NEWSWIRE) -- America’s Car-Mart, Inc. (NASDAQ: CRMT) (Car-Mart), one of the largest publicly held automotive retailers in the United States focused exclusively on the “Integrated Auto Sales and Finance” segment of the used car market, announced today the appointment of Jamie Fischer as Chief Operating Officer (COO), effective October 7th, 2024. She will oversee dealership operations and related support functions including inventory management and marketing. Jamie joins the compan...
America’s Car-Mart, Inc. Announces Pricing of Public Offering of Common Stock ROGERS, Ark., Sept. 19, 2024 (GLOBE NEWSWIRE) -- America’s Car-Mart, Inc. (NASDAQ: CRMT) (“Car-Mart” or the “Company”), a large publicly held automotive retailer focused exclusively on the “Integrated Auto Sales and Finance” segment of the used car market, announced today the pricing of its underwritten public offering of 1,700,000 shares of its common stock at a price to the public of $43.00 per share. In addition, Car-Mart has granted the underwriters a 30-day option to purchase up to an additional 255,000 sha...
America’s Car-Mart, Inc. Announces Proposed $65 Million Underwritten Public Offering Of Common Stock ROGERS, Ark., Sept. 18, 2024 (GLOBE NEWSWIRE) -- America’s Car-Mart, Inc. (NASDAQ: CRMT) (“Car-Mart” or the “Company”), a large publicly held automotive retailer focused exclusively on the “Integrated Auto Sales and Finance” segment of the used car market, announced today that it intends to offer and sell, subject to market and other conditions, $65,000,000 of shares of common stock in an underwritten public offering. In addition, Car-Mart intends to grant the underwriters a 30-day option ...
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) DALLAS, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on September 3, 2024, the Compensation Committee of Taysha's Board of Directors granted one new employee an option to purchase 311,000 shares of the Company's common stock in connection with their employment. The stock opti...
America’s Car-Mart Reports First Quarter Fiscal Year 2025 Results ROGERS, Ark., Sept. 04, 2024 (GLOBE NEWSWIRE) -- America’s Car-Mart, Inc. (NASDAQ: CRMT) (“we,” “Car-Mart” or the “Company”), today reported financial results for the first quarter ended July 31, 2024. First Quarter Key Highlights (FY'25 vs. FY'24 Q1, unless otherwise noted) Revenue was $347.8 million, down 5.2%Interest income increased $4.1 million, up 7.2%Total collections increased 4.3% to $172.9 millionFavorable adjustment to allowance for credit loss to 25.0%, down from 25.32%Net charge-offs as a % of average finance...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.